内分泌科

订阅

MedSci主页 / 所有栏目 / 内分泌科

J Endocrinol：中国扬州大学糖尿病研究新突破，来氟米特可将血糖恢复正常

2018-03-05 佚名 Healio

糖尿病
关注

根据发表在《内分泌学杂志》上的研究发现，来氟米特作为类风湿关节炎治疗中的活性代谢物，可以抑制一种影响小鼠胰岛素受体信号的蛋白质，从而使抗炎药物成为治疗2型糖尿病的潜在有效药物。

根据发表在《内分泌学杂志》上的研究发现，来氟米特作为类风湿关节炎治疗中的活性代谢物，可以抑制一种影响小鼠胰岛素受体信号的蛋白质，从而使抗炎药物成为治疗2型糖尿病的潜在有效药物。

类风湿关节炎患者患2型糖尿病和肥胖症的风险比没有类风湿关节炎的人高，中国扬州大学比较医学研究所的研究人员们指出，目前，类风湿关节炎和糖尿病患者分别使用糖尿病和类风湿关节炎药物治疗，针对这两种情况的治疗都会使两种情况都受益。

研究人员们在一份新闻稿中说：“我们研究了来氟米特是如何在分子水平上起作用的，发现它的目标是一种与胰岛素受体脱敏有关的蛋白质，它负责指示细胞开始从血液中吸收糖，我们知道一些炎症因子也能使胰岛素受体失敏，而来氟米特是一种抗炎药，因此它可能部分通过抗炎作用来控制血糖。”

研究人员发现，作为来氟米特的一种活性代谢物，A771726对S6K1活性的抑制作用使得胰岛素受体信号在正常和胰岛素抵抗条件下对小鼠肌管以及脂肪细胞中的抑制作用。

研究人员还研究了来氟米特对肥胖和高脂饮食诱导的糖尿病小鼠模型以及正常饮食小鼠的抗高血糖作用。他们发现来氟米特治疗使血糖水平正常化，并克服了高脂肪饮食小鼠的胰岛素抵抗和胰岛素耐受试验；然而，治疗对正常饮食的小鼠没有影响。

原始出处：

Junhong Chen, Jing Sun, Michelle E Doscas, et.al.Control of hyperglycemia in male mice by leflunomide: mechanisms of action. Journal of Endocrinology April 1, 2018

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1724975, encodeId=4f5e1e24975ad, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Jan 21 05:19:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294955, encodeId=2235294955a9, content=又多一个靶点.学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=990b2151290, createdName=177200fc66m, createdTime=Sat Mar 10 21:54:57 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293625, encodeId=12b2293625c7, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 06 20:05:35 CST 2018, time=2018-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293294, encodeId=96a72932941a, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:44 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293285, encodeId=d0442932853d, content=类风湿关节炎和糖尿病患者分别使用糖尿病和类风湿关节炎药物治疗.针对这两种情况的治疗都会使两种情况都受益., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Mon Mar 05 18:54:44 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2019-01-21 zxxiang

    #新突破#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1724975, encodeId=4f5e1e24975ad, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Jan 21 05:19:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294955, encodeId=2235294955a9, content=又多一个靶点.学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=990b2151290, createdName=177200fc66m, createdTime=Sat Mar 10 21:54:57 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293625, encodeId=12b2293625c7, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 06 20:05:35 CST 2018, time=2018-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293294, encodeId=96a72932941a, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:44 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293285, encodeId=d0442932853d, content=类风湿关节炎和糖尿病患者分别使用糖尿病和类风湿关节炎药物治疗.针对这两种情况的治疗都会使两种情况都受益., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Mon Mar 05 18:54:44 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2018-03-10 177200fc66m

    又多一个靶点.学习了!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1724975, encodeId=4f5e1e24975ad, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Jan 21 05:19:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294955, encodeId=2235294955a9, content=又多一个靶点.学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=990b2151290, createdName=177200fc66m, createdTime=Sat Mar 10 21:54:57 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293625, encodeId=12b2293625c7, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 06 20:05:35 CST 2018, time=2018-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293294, encodeId=96a72932941a, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:44 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293285, encodeId=d0442932853d, content=类风湿关节炎和糖尿病患者分别使用糖尿病和类风湿关节炎药物治疗.针对这两种情况的治疗都会使两种情况都受益., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Mon Mar 05 18:54:44 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2018-03-06 虈亣靌

    学习了.涨知识了!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1724975, encodeId=4f5e1e24975ad, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Jan 21 05:19:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294955, encodeId=2235294955a9, content=又多一个靶点.学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=990b2151290, createdName=177200fc66m, createdTime=Sat Mar 10 21:54:57 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293625, encodeId=12b2293625c7, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 06 20:05:35 CST 2018, time=2018-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293294, encodeId=96a72932941a, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:44 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293285, encodeId=d0442932853d, content=类风湿关节炎和糖尿病患者分别使用糖尿病和类风湿关节炎药物治疗.针对这两种情况的治疗都会使两种情况都受益., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Mon Mar 05 18:54:44 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2018-03-05 惠映实验室

    学习.谢谢分享.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1724975, encodeId=4f5e1e24975ad, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Mon Jan 21 05:19:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294955, encodeId=2235294955a9, content=又多一个靶点.学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=990b2151290, createdName=177200fc66m, createdTime=Sat Mar 10 21:54:57 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293625, encodeId=12b2293625c7, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 06 20:05:35 CST 2018, time=2018-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293294, encodeId=96a72932941a, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:44 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293285, encodeId=d0442932853d, content=类风湿关节炎和糖尿病患者分别使用糖尿病和类风湿关节炎药物治疗.针对这两种情况的治疗都会使两种情况都受益., beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Mon Mar 05 18:54:44 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2018-03-05 沙漠浪人

    类风湿关节炎和糖尿病患者分别使用糖尿病和类风湿关节炎药物治疗.针对这两种情况的治疗都会使两种情况都受益.

    0

相关资讯

Brit J Cancer：母亲糖尿病与子代儿童期急性淋巴细胞白血病风险！

由此可见，尽管糖尿病妇女子代发生ALL的绝对风险很低，该研究结果表明糖尿病宫内环境的特点促进了ALL的发生发展。这为将来研究儿童期ALL的生物学机制提供了一个研究背景。

ACC:首次证实！阿司匹林可降低糖尿病和心衰患者死亡风险，但……

发表在美国心脏病学会第67届年度科学会议上的一项研究称，对患有2型糖尿病和心力衰竭的人来说，每天服用阿司匹林似乎能够降低死亡或因心衰住院的风险。但数据也显示，阿司匹林的使用可能会增加患非致命性心脏病或中风的风险。这一有点矛盾的发现，让研究人员感到惊讶。

Plos One：七氟醚可进一步增加慢性糖尿病患者QTc间期的延长

七氟醚可显著延长QTc间期，且慢性糖尿病患者的延长程度明显大于血糖正常的患者。尽管Tp-ec不受七氟醚影响，但应该指出，同时阻断钾离子通道会增加心律失常的风险。

孕期OGTT筛查的“不符”结果怎么解？

孕期OGTT的筛查主要用于孕期糖尿病的筛查，我国目前由卫生部公布的妊娠糖尿病诊断规范中推荐的诊断方法及标准与国际妊娠与糖尿病研究组织(IADPSG)推荐的大体一致，即口服75g葡萄糖负荷进行葡萄糖耐量试验(OGTT)一步法。

Lancet Diabetes Endo：提出五种类型而不是两种，是糖尿病量身定制治疗一大步！

患有糖尿病的成年人可以从更好的治疗中获益，如果这种情况被归类为五种类型，而不是仅仅两种。这是发表在《柳叶刀-糖尿病与内分泌学》杂志上的一项新研究的结论。

Thromb Haemostasis：糖尿病AF患者 哪种抗凝药是当之无愧的王者？

“年年岁岁花相似，岁岁年年人不同”，近年来随着经济的迅猛发展，人们的生活水平得到了显著改善。在人们尽情享受美好生活的同时，殊不知许多疾病也在慢慢的向我们逼近，尤其是糖尿病，发病率不断攀升。